Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 532 | 26,881 | 923 | 911 | 545 |
| Cost of Goods | 410 | 2,104 | N/A | N/A | N/A |
| Gross Profit | 122 | 24,777 | 923 | 911 | 545 |
| Operating Expenses | 10,774 | 15,039 | 23,997 | 30,387 | 35,429 |
| Operating Income | -10,242 | 9,842 | -23,074 | -29,476 | -34,884 |
| Other Income | 4,012 | -203 | 2,799 | 4,517 | -15,344 |
| Pre-tax Income | -6,230 | 9,639 | -20,275 | -24,959 | -50,228 |
| Income Tax | -188 | 5,452 | -3,479 | N/A | N/A |
| Net Income Continuous | -6,042 | 4,187 | -16,796 | -24,959 | -50,228 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 85 |
| Net Income | $-6,042 | $4,187 | $-16,796 | $-24,959 | $-50,143 |
| EPS Basic Total Ops | -35.00 | 25.00 | -112.00 | -241.00 | -1,814.00 |
| EPS Basic Continuous Ops | -34.54 | 25.47 | -112.28 | -241.18 | -1,817.48 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 3.08 |
| EPS Diluted Total Ops | -35.00 | 24.00 | -112.00 | -241.00 | -1,814.00 |
| EPS Diluted Continuous Ops | -34.54 | 24.58 | -112.28 | -241.18 | -1,817.48 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 3.08 |
| EPS Diluted Before Non-Recurring Items | -53.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-10,001 | $9,291 | $-23,438 | $-29,541 | $-34,791 |